GSK's CEO Emma Walmsley will step down in December and be replaced by insider Luke Miels, the British drugmaker said on Monday, tasking the new leader to deliver shareholder value and prepare for the ...
GSK will use AI, dual sourcing to offset tariff hit Q1 results better-than-expected Shares up 3.8% Maintains 2025 turnover and profit forecasts April 30 (Reuters) - GSK (GSK.L), opens new tab on ...
As GSK weathers the storm of sinking vaccine sales and gears up for key launches in its specialty medicines sector, the British drug giant feels prepared for any challenges that U.S. drug import ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results